Healon in retinal detachment with proliferative vitreoretinopathy.
In 73 eyes, retinal detachments complicated by proliferative vitreoretinopathy (PVR) were treated by intravitreal injections of Healon, in addition to scleral buckling procedures. The number of completely reattached retinas three months postoperatively was dependent upon the grade of PVR: 50% were reattached when PVR comprised only one quadrant (Grade C-1); 30% when two to four quadrants were involved (Grade C-2, C-3 and D-1). Reattachment was not achieved in two cases of PVR with funnel-like configurations (D-2). Major complications that could be attributed to Healon did not occur. The results indicate that Healon injections, combined with scleral buckling procedures, are an encouraging approach to retinal detachments with PVR Grades C-2 through D-1.
D003131:Combined Modality Therapy; D005128:Eye Diseases / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D012163:Retinal Detachment / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D012164:Retinal Diseases / Q000150:complications / Q000188:drug therapy*; D012591:Scleral Buckling; D014792:Visual Acuity; D014822:Vitreous Body
D006820:Hyaluronic Acid